GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (NAS:FBIO) » Definitions » E10

FBIO (Fortress Biotech) E10 : $-19.82 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fortress Biotech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fortress Biotech's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.760. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-19.82 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Fortress Biotech was 13.90% per year. The lowest was 13.90% per year. And the median was 13.90% per year.

As of today (2024-12-11), Fortress Biotech's current stock price is $2.12. Fortress Biotech's E10 for the quarter that ended in Sep. 2024 was $-19.82. Fortress Biotech's Shiller PE Ratio of today is .


Fortress Biotech E10 Historical Data

The historical data trend for Fortress Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech E10 Chart

Fortress Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -29.66 -19.54 -19.86 -18.95

Fortress Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.50 -18.95 -18.98 -19.93 -19.82

Competitive Comparison of Fortress Biotech's E10

For the Biotechnology subindustry, Fortress Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortress Biotech's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortress Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fortress Biotech's Shiller PE Ratio falls into.



Fortress Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fortress Biotech's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.76/133.0289*133.0289
=-0.760

Current CPI (Sep. 2024) = 133.0289.

Fortress Biotech Quarterly Data

per share eps CPI Adj_EPS
201412 -1.500 99.070 -2.014
201503 -4.650 99.621 -6.209
201506 -2.400 100.684 -3.171
201509 -6.900 100.392 -9.143
201512 -4.650 99.792 -6.199
201603 -4.650 100.470 -6.157
201606 -4.650 101.688 -6.083
201609 -4.800 101.861 -6.269
201612 -6.600 101.863 -8.619
201703 -4.500 102.862 -5.820
201706 -6.450 103.349 -8.302
201709 -10.050 104.136 -12.838
201712 -3.300 104.011 -4.221
201803 -7.350 105.290 -9.286
201806 -7.500 106.317 -9.384
201809 -5.550 106.507 -6.932
201812 -8.700 105.998 -10.919
201903 0.300 107.251 0.372
201906 -3.600 108.070 -4.431
201909 -3.300 108.329 -4.052
201912 -4.050 108.420 -4.969
202003 -2.850 108.902 -3.481
202006 -2.850 108.767 -3.486
202009 -3.000 109.815 -3.634
202012 -0.900 109.897 -1.089
202103 -1.650 111.754 -1.964
202106 -0.600 114.631 -0.696
202109 -3.900 115.734 -4.483
202112 -5.700 117.630 -6.446
202203 -2.700 121.301 -2.961
202206 -3.900 125.017 -4.150
202209 -4.112 125.227 -4.368
202212 -4.814 125.222 -5.114
202303 -3.470 127.348 -3.625
202306 -3.650 128.729 -3.772
202309 -0.940 129.860 -0.963
202312 -0.530 129.419 -0.545
202403 -1.030 131.776 -1.040
202406 -10.950 132.554 -10.989
202409 -0.760 133.029 -0.760

Add all the adjusted EPS together and divide 10 will get our e10.


Fortress Biotech  (NAS:FBIO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fortress Biotech E10 Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Fortress Biotech Business Description

Traded in Other Exchanges
Address
1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
Executives
Rosenwald Lindsay A Md director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN 375 PARK AVE, NEW YORK NY 10152
Dov Klein director C/O FORTRESS BIOTECH, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK NY 10019
Lucy Lu director THE FEMALE HEALTH COMPANY, 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137
David Jin officer: Chief Financial Officer C/O AVENUE THERAPEUTICS, INC., 1140 AVENUE OF THE AMERICAS, FLOOR 9, NEW YORK NY 10036
Robyn Hunter officer: Chief Financial Officer 95 SAWYER ROAD, SUITE 110, WALTHAM MA 02453
Eric K Rowinsky director IMCLONE SYSTEMS INCORPORATED, 180 VARICK STREET, 6TH FLOOR, NEW YORK NY 10014
Malcolm Hoenlein director 750 LEXINGTON AVENUE, NEW YORK NY 10022
Jimmie Harvey director 3741 EAST FAIRWAY DRIVE, BIRMINGHAM AL 35213
J Jay Lobell director 365 W END AVE, APARTMENT 10A, NEW YORK NY 10024
Michael S Weiss director, 10 percent owner, officer: EXECUTIVE VICE CHAIRMAN 750 LEXINGTON AVE, NEW YORK NY 10022
Kevin Lorenz director C/O NUVEEN, 333 W. WACKER DR., CHICAGO IL 60606
George Avgerinos officer: SVP, Biologics Operations C/O CORONADO BIOSCIENCES, INC., 24 NEW ENGLAND EXECUTIVE PARK, BURLINGTON MA 01803
Kevin Horgan other: Former Chief Medical Officer C/O SOLIGENIX, INC., 29 EMMONS DRIVE, STE. C-10, PRINCETON NJ 08540
David Jonathan Barrett director ONE PENN PLAZA, SUITE 2514, NEW YORK NY 10119
Harlan F Weisman director C/O CORONADO BIOSCIENCES, INC., 15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON MA 01803